Although, reports implicate ATP13A3 gene mutations in the pathogenicity of pulmonary arterial hypertension (PAH) and its altered expression has been reported in cervical and pancreatic cancers, its regulation and molecular characteristics are still poorly elucidated16–19. Here, ATP13A3 is linked to pulmonary arterial hypertension.